Giulio Sartori

454 total citations
20 papers, 154 citations indexed

About

Giulio Sartori is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Giulio Sartori has authored 20 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Giulio Sartori's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Giulio Sartori is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Giulio Sartori collaborates with scholars based in Switzerland, Italy and United States. Giulio Sartori's co-authors include Giancarlo Lancini, Francesco Bertoni, Emanuele Zucca, Eliana Pivetta, Alfonso Colombatti, Alessandra Capuano, Roberto Doliana, Paola Spessotto, Chiara Tarantelli and Filippo Spriano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Cellular and Molecular Life Sciences.

In The Last Decade

Giulio Sartori

19 papers receiving 145 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Giulio Sartori 95 44 27 23 17 20 154
Alessandra Donadini 195 2.1× 60 1.4× 24 0.9× 54 2.3× 17 1.0× 16 363
Nicole Pinto 143 1.5× 97 2.2× 26 1.0× 21 0.9× 21 1.2× 21 261
Kateřina Growková 136 1.4× 51 1.2× 24 0.9× 14 0.6× 18 1.1× 12 188
Bonnie Huor 230 2.4× 57 1.3× 19 0.7× 9 0.4× 28 1.6× 2 268
Sheng-Ben Liang 142 1.5× 51 1.2× 18 0.7× 16 0.7× 42 2.5× 5 190
Bahman Zarandi 100 1.1× 61 1.4× 14 0.5× 14 0.6× 14 0.8× 7 186
Cécile K. Lopez 148 1.6× 23 0.5× 20 0.7× 24 1.0× 45 2.6× 13 227
Tommaso Perini 156 1.6× 60 1.4× 22 0.8× 13 0.6× 35 2.1× 19 263
Sridhar Kavela 340 3.6× 104 2.4× 21 0.8× 23 1.0× 27 1.6× 13 403
Heidie Frisco Cabanos 89 0.9× 64 1.5× 8 0.3× 9 0.4× 19 1.1× 4 161

Countries citing papers authored by Giulio Sartori

Since Specialization
Citations

This map shows the geographic impact of Giulio Sartori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulio Sartori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulio Sartori more than expected).

Fields of papers citing papers by Giulio Sartori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulio Sartori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulio Sartori. The network helps show where Giulio Sartori may publish in the future.

Co-authorship network of co-authors of Giulio Sartori

This figure shows the co-authorship network connecting the top 25 collaborators of Giulio Sartori. A scholar is included among the top collaborators of Giulio Sartori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulio Sartori. Giulio Sartori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasi, Binu K., Chiara Tarantelli, Giulio Sartori, et al.. (2025). Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies. Haematologica. 110(12). 2974–2985. 1 indexed citations
2.
Sartori, Giulio, Chiara Tarantelli, Filippo Spriano, et al.. (2023). The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib. British Journal of Haematology. 204(1). 191–205. 7 indexed citations
3.
Chung, Elaine Y., Giulio Sartori, Maurilio Ponzoni, et al.. (2023). ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. British Journal of Haematology. 203(2). 244–254. 2 indexed citations
4.
Guidetti, Francesca, Alberto J. Arribas, Giulio Sartori, et al.. (2023). Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of Clinical Medicine. 12(2). 399–399. 10 indexed citations
5.
Mensah, Afua A., Giulio Sartori, Filippo Spriano, et al.. (2023). Abstract C144: MEN1703/SEL24, a potent PIM inhibitor, demonstrates promising anti-tumour activity in activated B cell like diffuse large B cell lymphoma, mantle cell lymphoma and marginal zone lymphoma cells. Molecular Cancer Therapeutics. 22(12_Supplement). C144–C144. 2 indexed citations
6.
Spriano, Filippo, Giulio Sartori, Chiara Tarantelli, et al.. (2022). Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma. SHILAP Revista de lepidopterología. 3(3). 764–774. 2 indexed citations
7.
Sartori, Giulio, et al.. (2022). Abstract 2655: The GPCR OR13A1 is essential for lymphoma cells. Cancer Research. 82(12_Supplement). 2655–2655.
8.
Mensah, Afua A., Sérgio Valente, Giulio Sartori, et al.. (2022). Abstract 3279: Dual inhibition of EZH2 and histone deacetylases for the treatment of lymphomas with epigenetic aberrations. Cancer Research. 82(12_Supplement). 3279–3279. 1 indexed citations
9.
Mensah, Afua A., Filippo Spriano, Giulio Sartori, et al.. (2021). Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors. Blood Advances. 5(10). 2467–2480. 12 indexed citations
10.
Sartori, Giulio, Sara Napoli, Luciano Cascione, et al.. (2021). ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma. Journal of Experimental & Clinical Cancer Research. 40(1). 357–357. 8 indexed citations
11.
Napoli, Sara, Luciano Cascione, Andrea Rinaldi, et al.. (2021). Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma. Haematologica. 107(5). 1131–1143. 1 indexed citations
12.
Jessen‐Trefzer, Claudia, Dimitrios Spiliotopoulos, Eugenio Gaudio, et al.. (2020). Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors. RSC Medicinal Chemistry. 11(6). 665–675. 6 indexed citations
13.
Arribas, Alberto J., Sara Napoli, Luciano Cascione, et al.. (2020). Abstract PO-46: Mechanisms of resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma. Blood Cancer Discovery. 1(3_Supplement). PO–46. 2 indexed citations
14.
Sartori, Giulio, Sara Napoli, Elaine Y. Chung, et al.. (2020). Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type. Cancers. 12(7). 1912–1912. 6 indexed citations
15.
Arribas, Alberto J., Sara Napoli, Luciano Cascione, et al.. (2020). Secondary resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma. European Journal of Cancer. 138. S40–S40. 6 indexed citations
16.
Capuano, Alessandra, Eliana Pivetta, Giulio Sartori, et al.. (2019). Abrogation of EMILIN1-β1 integrin interaction promotes experimental colitis and colon carcinogenesis. Matrix Biology. 83. 97–115. 24 indexed citations
17.
Tarantelli, Chiara, Eugenio Gaudio, Petra Hillmann, et al.. (2019). The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax. Cancers. 11(6). 775–775. 12 indexed citations
18.
Arribas, Alberto J., Sara Napoli, Eugenio Gaudio, et al.. (2019). Abstract A127: Secretion of IL16 is associated with resistance to ibrutinib in pre-clinical models of lymphoma. Molecular Cancer Therapeutics. 18(12_Supplement). A127–A127. 2 indexed citations
19.
Sartori, Giulio, Eliana Pivetta, Roberto Doliana, et al.. (2017). The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth. Oncotarget. 8(16). 27034–27046. 17 indexed citations
20.
Lancini, Giancarlo & Giulio Sartori. (1968). Rifamycins LXI: In vivo inhibition of RNA synthesis by rifamycins. Cellular and Molecular Life Sciences. 24(11). 1105–1106. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Donadini Breakdown of academic impact, for papers by Nicole Pinto Breakdown of academic impact, for papers by Kateřina Growková Breakdown of academic impact, for papers by Bonnie Huor Breakdown of academic impact, for papers by Sheng-Ben Liang Breakdown of academic impact, for papers by Bahman Zarandi Breakdown of academic impact, for papers by Cécile K. Lopez Breakdown of academic impact, for papers by Tommaso Perini Breakdown of academic impact, for papers by Sridhar Kavela Breakdown of academic impact, for papers by Heidie Frisco Cabanos
Rankless by CCL
2026